(JREG) JPMorgan s (Ireland) ICAV - Overview
Etf: Equities, Global, Large-Cap, Tech, Finance
| Risk 5d forecast | |
|---|---|
| Volatility | 12.9% |
| Relative Tail Risk | -3.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.05 |
| Alpha | -2.37 |
| Character TTM | |
|---|---|
| Beta | 0.196 |
| Beta Downside | 0.426 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.42% |
| CAGR/Max DD | 0.74 |
Description: JREG JPMorgan s (Ireland) ICAV January 01, 2026
The JPMorgan ETFs (Ireland) ICAV – Global Research Enhanced Index Equity UCITS ETF (USD-acc) (XETRA:JREG) seeks to outperform its benchmark, the Morningstar Global TME NR USD index, by actively selecting a diversified set of global large-cap equities. The fund is domiciled in Germany and trades under the ticker JREG, positioning itself within the Global Large-Cap Blend Equity category.
Key metrics as of the latest reporting period show an expense ratio of 0.30% and assets under management of roughly €2.1 bn, indicating solid investor interest for a relatively young ETF launched in 2022. The portfolio’s top ten holdings are heavily weighted toward U.S. technology and consumer discretionary firms, reflecting the sector’s outsized contribution to global earnings growth. Recent macro-drivers-namely resilient corporate profit margins, a moderate decline in global inflation, and stabilising monetary policy-support the fund’s long-term excess-return objective.
For a deeper dive into the fund’s risk-adjusted performance and sector tilt, consider exploring ValueRay’s analytical tools, which can help you gauge whether JREG aligns with your investment thesis.
What is the price of JREG shares?
Over the past week, the price has changed by +0.60%, over one month by +0.00%, over three months by +2.95% and over the past year by +3.87%.
Is JREG a buy, sell or hold?
What are the forecasts/targets for the JREG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 58.9 | 12.5% |
JREG Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 234.4m EUR (234.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 234.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 234.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.64% (E(234.4m)/V(234.4m) * Re(6.64%) + (debt-free company))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)